Nexus Surgical re-designates Ram Swaroop Joshi to promoter director

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Nexus Surgical and Medicare Limited re-designated Ram Swaroop Joshi to Promoter Non-Executive Director
  • Change effective from close of business on September 2, 2026
  • Shareholders approved the move at the 35th Annual General Meeting held on September 25, 2026
  • Disclosure filed with BSE under Regulation 30 of SEBI LODR Regulations, 2015
powered bylight_fuzz_icon
51967584

*this image is generated using AI for illustrative purposes only.

Nexus Surgical and Medicare Limited has approved the re-designation of Ram Swaroop Joshi from Professional Non-Executive Director to Promoter Non-Executive Director. The change is effective from the close of business hours on September 2, 2026.

The decision was ratified by shareholders during the company's 35th Annual General Meeting. The meeting took place on September 25, 2026, at 12:30 pm via video conferencing. This move aligns Joshi's board role with his promoter status within the organization.

Regulatory disclosure details

The company filed a formal disclosure with BSE Limited on September 26, 2026, citing Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that the members approved the specific change in director capacity following the AGM proceedings.

Detail Information
Director Name Ram Swaroop Joshi
DIN 07184085
Previous Role Professional Non-Executive Director
New Role Promoter Non-Executive Director
Effective Date September 2, 2026
Approval Date September 25, 2026

Governance implications

The re-designation signifies a shift in the classification of Joshi's directorship from professional to promoter category. Monika Choudhary, Company Secretary, signed the digital submission confirming these changes for corporate records. No financial figures or operational metrics were disclosed in this specific governance update.

Historical Stock Returns for Nexus Surgical & Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
-4.54%-5.31%+58.94%+79.94%+69.44%+970.18%

How will Ram Swaroop Joshi's re-designation to Promoter Non-Executive Director impact Nexus Surgical's compliance with SEBI's minimum independent director requirements?

What specific voting rights or board influence changes are anticipated for promoter directors compared to professional non-executive directors at Nexus Surgical?

Will this governance shift trigger any mandatory disclosures regarding related-party transactions or promoter shareholding patterns in upcoming quarterly filings?

Nexus Surgical & Medicare
View Company Insights
View All News
like19
dislike

Nexus Surgical AGM passes all resolutions; appoints Anish More as MD

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • All seven resolutions passed at the 35th AGM held on September 25, 2026
  • Anish More appointed as Managing Director for a 3-year term starting September 2, 2026
  • MD remuneration fixed at ₹24,00,000 per annum under Schedule V provisions
  • Voting turnout for most resolutions was approximately 46.6% of outstanding shares
powered bylight_fuzz_icon
51889714

*this image is generated using AI for illustrative purposes only.

Nexus Surgical and Medicare Limited held its 35th Annual General Meeting on September 25, 2026, via video conferencing. All seven resolutions were passed with requisite majority, including the appointment of Anish More as Managing Director for a three-year term.

Key resolutions passed

Shareholders approved seven resolutions spanning financial adoption and board-level governance. The proceedings were conducted in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Item Resolution details Type
1 Adoption of audited financial statements for FY26 Ordinary
2 Re-appointment of Pawankumar Choudhary as director Ordinary
3 Appointment of Anish More as director Ordinary
4 Appointment of Anish More as Managing Director Ordinary
5 Re-designation of Ram Swaroop Joshi to Promoter Non-Executive Director Ordinary
6 Appointment of Ashish Durgaprasad Mishra as Independent Director Special
7 Re-appointment of Neha Kailash Bhageria as Independent Woman Director for a second term of 5 years Special

Managing Director appointment details

The members approved the appointment of Anish More (DIN 11070098) as Managing Director for a period of 3 years from September 2, 2026, to September 1, 2029. The remuneration approved is ₹24,00,000 per annum, in accordance with Schedule V of the Companies Act, 2013, given the company's inadequate profits. More holds an M.S. from the University of California, Riverside, and a B.E. in Computer Engineering. He is a co-founder of Saans AI and has experience in healthcare technology and cloud infrastructure. He is not related to any other director or key managerial personnel and is not debarred from holding office.

Governance and attendance

Ram Swaroop Joshi chaired the meeting, welcoming members and introducing the board. Independent Directors Surya Kant Modi, Ashish Durgaprasad Mishra, and Neha Bhageria attended. Pawankumar Choudhary served as Director and Chief Financial Officer, while Anish More was introduced as Professional Executive Director. Monika Choudhary acted as Company Secretary and Compliance Officer. Statutory auditor Satya Prakash Natani from M/s. Satya Prakash Natani & Co. and secretarial auditor Narottam Bagaria from M/s. N. Bagaria & Associates also participated virtually.

Voting results

The company provided remote e-voting through Purva Sharegistry (India) Private Limited, with the voting period running from September 22, 2026 (9:00 am) to September 24, 2026 (5:00 pm). Members who had not voted remotely were given the facility to vote at the AGM. The cut-off date for voting eligibility was September 18, 2026. As on the record date, the total number of shareholders stood at 5,925. The consolidated scrutinizer's report was prepared by CS Narottam Bagaria, Partner, M/s. N. Bagaria & Associates.

The table below presents the agenda-wise voting summary across all seven resolutions.

Resolution Total votes polled Votes in favour Votes against % in favour % polled on outstanding shares
1 — Adoption of FY26 financial statements 2,550,267 2,550,262 5 99.9998 46.6066
2 — Re-appointment of Pawankumar Choudhary 2,550,267 2,550,207 60 99.9976 46.6066
3 — Appointment of Anish More as director 2,550,267 2,550,207 60 99.9976 46.6066
4 — Appointment of Anish More as Managing Director 2,550,267 2,550,207 60 99.9976 46.6066
5 — Re-designation of Ram Swaroop Joshi* 1,535,267 1,535,207 60 99.9961 28.0573
6 — Appointment of Ashish Durgaprasad Mishra as Independent Director 2,550,267 2,550,207 60 99.9976 46.6066
7 — Re-appointment of Neha Kailash Bhageria as Independent Woman Director 2,550,267 2,550,207 60 99.9976 46.6066

*The Promoter/Promoter Group was interested in Resolution 5 and abstained from voting in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Accordingly, the promoter group's 1,025,000 shares were excluded from the vote count for this resolution.

Compliance and post-meeting disclosures

Resolutions 1 to 5 were deemed passed as ordinary resolutions, while Resolutions 6 and 7 were passed as special resolutions. The annual report containing the Board's Report and Auditors' Report was circulated electronically. Consolidated voting results were submitted to BSE Limited and published on the company website within two working days. The meeting concluded at 12:45 pm.

Historical Stock Returns for Nexus Surgical & Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
-4.54%-5.31%+58.94%+79.94%+69.44%+970.18%

How will Anish More's background in healthcare technology and AI influence Nexus Surgical's strategic pivot or product innovation over the next three years?

What specific operational or financial turnaround plans has the new Managing Director outlined to address the company's inadequate profits that necessitated Schedule V remuneration?

Will the re-designation of Ram Swaroop Joshi to Promoter Non-Executive Director lead to any changes in the company's promoter holding structure or governance dynamics?

Nexus Surgical & Medicare
View Company Insights
View All News
like17
dislike

More News on Nexus Surgical & Medicare

1 Year Returns:+69.44%